Want to join the conversation?
$COL 3Q15 10-Q: 3Q15-end: Cash and cash equivalents were $294MM, down 34.67% from $450MM at 3Q14-end. Net long-term debt was $1,667MM, up 0.24% from $1,663MM at 3Q14-end. YTD 2015: Total revenues increased 8% driven by ARINC acquisition and 8% increase in Commercial Systems revenues. Diluted EPS from continuing operations increased 17% to $3.81.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)